Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice

[1]  D. Karanja,et al.  Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya , 2009, Tropical medicine & international health : TM & IH.

[2]  M. Tanner,et al.  Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine , 2009, Parasitology Research.

[3]  M. Tanner,et al.  Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice , 2009, PLoS neglected tropical diseases.

[4]  Jürg Utzinger,et al.  Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis , 2008, Current opinion in infectious diseases.

[5]  Jozef Vercruysse,et al.  Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. , 2008, Travel medicine and infectious disease.

[6]  Anton Simeonov,et al.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis , 2008, Nature Medicine.

[7]  P. Brindley,et al.  RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade. , 2008, Molecular and biochemical parasitology.

[8]  J. Utzinger,et al.  Drugs for treating urinary schistosomiasis , 2014, The Cochrane database of systematic reviews.

[9]  J. Utzinger,et al.  Advances in the discovery and development of trematocidal drugs , 2007, Expert opinion on drug discovery.

[10]  C. Caffrey,et al.  Chemotherapy of schistosomiasis: present and future. , 2007, Current opinion in chemical biology.

[11]  E. Davioud‐Charvet,et al.  Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target , 2007, PLoS medicine.

[12]  M. Tanner,et al.  In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species , 2007, Antimicrobial Agents and Chemotherapy.

[13]  M. Tanner,et al.  Artemisinins for schistosomiasis and beyond. , 2007, Current opinion in investigational drugs.

[14]  M. Sajid,et al.  Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor , 2007, PLoS medicine.

[15]  Marcel Tanner,et al.  Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. , 2006, The Lancet. Infectious diseases.

[16]  Ming-gang Chen.  Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience. , 2005, Acta tropica.

[17]  M. Tanner,et al.  Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology. , 2004, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.

[18]  I. Bogoch,et al.  Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  M. Todd,et al.  Drugs for the control of parasitic diseases: current status and development in schistosomiasis. , 2003, Trends in parasitology.

[20]  M. Tanner,et al.  Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire , 2003, Annals of tropical medicine and parasitology.

[21]  S. D. de Vlas,et al.  Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. , 2002, Trends in parasitology.

[22]  D. Fairlie,et al.  Proteolysis of human hemoglobin by schistosome cathepsin D. , 2001, Molecular and biochemical parasitology.

[23]  O. Doumbo,et al.  Reinfection by Schistosoma haematobium and mansoni despite repeated treatment with praziquantel in office Du Niger (Mali). , 2000 .

[24]  O. Doumbo,et al.  [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali]. , 2000, Medecine tropicale : revue du Corps de sante colonial.

[25]  M. Foley,et al.  Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. , 1998, Pharmacology & therapeutics.

[26]  M. Foley,et al.  Quinoline antimalarials: mechanisms of action and resistance. , 1997, International journal for parasitology.

[27]  Q. Liu,et al.  Factors contributing to reinfection with schistosomiasis japonica after treatment in the lake region of China. , 1993, Acta tropica.

[28]  Xiao Sh,et al.  Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. , 1987 .

[29]  A. Sher,et al.  The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. , 1987, Journal of immunology.

[30]  S. Xiao,et al.  Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. , 1987, Chinese medical journal.

[31]  C. Fletcher,et al.  Schistosoma mansoni: chemotherapy of infections of different ages. , 1986, Experimental parasitology.

[32]  C. Fletcher,et al.  Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. , 1985, Experimental parasitology.

[33]  J. Mei,et al.  [Prophylactic activity of praziquantel in animals infected with Schistosoma japonicum]. , 1985, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[34]  P. Andrews,et al.  Praziquantel: mechanisms of anti-schistosomal activity. , 1985, Pharmacology & therapeutics.

[35]  Xiao Sh,et al.  Preliminary studies on the mode of action of pyquiton against Schistosoma japonicum. , 1984 .

[36]  Y. Yu,et al.  Preliminary studies on the mode of action of pyquiton against Schistosoma japonicum. , 1984, Chinese medical journal.

[37]  F. Pc,et al.  Studies on morphological characteristics of Japanese strain of Schistosoma japonicum in rabbits. , 1976 .

[38]  J. D. Lawrence.  The ingestion of red blood cells by Schistosoma mansoni. , 1973, The Journal of parasitology.

[39]  A. R. Patel,et al.  Antimalarials. 7. Bis(trifluoromethyl)-.alpha.-(2-piperidyl)-4-quinolinemethanols , 1971 .

[40]  A. R. Patel,et al.  Antimalarials. 7. Bis(trifluoromethyl)- -(2-piperidyl)-4-quinolinemethanols. , 1971, Journal of medicinal chemistry.

[41]  R. Lewert,et al.  Pigment formation in Schistosoma mansoni infections in the white mouse. , 1966, The American journal of tropical medicine and hygiene.

[42]  T. K. Yolles,et al.  A technique for the perfusion of laboratory animals for the recovery of schistosomes. , 1947, The Journal of parasitology.